Previous close | 216.84 |
Open | 216.00 |
Bid | 205.97 x 800 |
Ask | 220.80 x 900 |
Day's range | 212.95 - 217.55 |
52-week range | 132.24 - 237.26 |
Volume | |
Avg. volume | 1,105,285 |
Market cap | 31.412B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 32.84 |
EPS (TTM) | 6.51 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.92 (0.89%) |
Ex-dividend date | 08 May 2024 |
1y target est | 212.34 |
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.